Morgan Stanley’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396K Buy
91,743
+11,853
+15% +$62.1K ﹤0.01% 5590
2025
Q4
$492K Buy
79,890
+43,928
+122% +$325K ﹤0.01% 5526
2025
Q3
$350K Buy
35,962
+14,111
+65% +$177K ﹤0.01% 5661
2025
Q2
$286K Buy
21,851
+10,217
+88% +$132K ﹤0.01% 5706
2025
Q1
$170K Sell
11,634
-2,102
-15% -$39.6K ﹤0.01% 5807
2024
Q4
$241K Sell
13,736
-1,196
-8% -$16.8K ﹤0.01% 5719
2024
Q3
$180K Sell
14,932
-1,937
-11% -$16K ﹤0.01% 5783
2024
Q2
$108K Sell
16,869
-715
-4% -$4.85K ﹤0.01% 5938
2024
Q1
$106K Sell
17,584
-17,208
-49% -$109K ﹤0.01% 5967
2023
Q4
$209K Buy
34,792
+19,374
+126% +$128K ﹤0.01% 5930
2023
Q3
$99.4K Sell
15,418
-4,975
-24% -$27.8K ﹤0.01% 5896
2023
Q2
$88.7K Sell
20,393
-15,804
-44% -$65.3K ﹤0.01% 6005
2023
Q1
$130K Sell
36,197
-1,537
-4% -$5.77K ﹤0.01% 5903
2022
Q4
$140K Sell
37,734
-22,244
-37% -$84.6K ﹤0.01% 5818
2022
Q3
$226K Sell
59,978
-9,236
-13% -$37.4K ﹤0.01% 5676
2022
Q2
$301K Sell
69,214
-16,121
-19% -$70.4K ﹤0.01% 5686
2022
Q1
$406K Buy
85,335
+1,812
+2% +$10.1K ﹤0.01% 5522
2021
Q4
$527K Sell
83,523
-119,161
-59% -$811K ﹤0.01% 5513
2021
Q3
$1.37M Sell
202,684
-81,618
-29% -$600K ﹤0.01% 4842
2021
Q2
$2.09M Sell
284,302
-59,126
-17% -$483K ﹤0.01% 4599
2021
Q1
$3.21M Buy
343,428
+103,633
+43% +$967K ﹤0.01% 3861
2020
Q4
$2.23M Buy
239,795
+167,705
+233% +$1.88M ﹤0.01% 4052
2020
Q3
$871K Buy
72,090
+61,655
+591% +$833K ﹤0.01% 4315
2020
Q2
$141K Buy
10,435
+5,955
+133% +$82.6K ﹤0.01% 5239
2020
Q1
$46K Sell
4,480
-18,125
-80% -$248K ﹤0.01% 5491
2019
Q4
$353K Buy
22,605
+9,492
+72% +$140K ﹤0.01% 5122
2019
Q3
$180K Buy
13,113
+8,399
+178% +$102K ﹤0.01% 5182
2019
Q2
$61K Sell
4,714
-6,417
-58% -$76.3K ﹤0.01% 5524
2019
Q1
$159K Buy
11,131
+5,456
+96% +$79.2K ﹤0.01% 5181
2018
Q4
$75K Sell
5,675
-598
-10% -$7.16K ﹤0.01% 5648
2018
Q3
$69K Buy
6,273
+1,647
+36% +$17.6K ﹤0.01% 5797
2018
Q2
$29K Buy
4,626
+220
+5% +$1K ﹤0.01% 6054
2018
Q1
$16K Sell
4,406
-3,681
-46% -$15.6K ﹤0.01% 6172
2017
Q4
$39K Buy
8,087
+6,072
+301% +$31.9K ﹤0.01% 5890
2017
Q3
$9K Sell
2,015
-356
-15% -$1.4K ﹤0.01% 6192
2017
Q2
$10K Sell
2,371
-27,660
-92% -$122K ﹤0.01% 6239
2017
Q1
$162K Sell
30,031
-22,412
-43% -$141K ﹤0.01% 5415
2016
Q4
$427K Buy
52,443
+21,646
+70% +$185K ﹤0.01% 5022
2016
Q3
$292K Buy
30,797
+17,362
+129% +$226K ﹤0.01% 4816
2016
Q2
$183K Sell
13,435
-9,119
-40% -$104K ﹤0.01% 4984
2016
Q1
$206K Sell
22,554
-7,484
-25% -$66.5K ﹤0.01% 4956
2015
Q4
$286K Sell
30,038
-9,306
-24% -$70.2K ﹤0.01% 4894
2015
Q3
$223K Buy
39,344
+4,464
+13% +$21.4K ﹤0.01% 5030
2015
Q2
$129K Sell
34,880
-18,546
-35% -$85.7K ﹤0.01% 5454
2015
Q1
$295K Sell
53,426
-16,028
-23% -$115K ﹤0.01% 4990
2014
Q4
$632K Sell
69,454
-3,134
-4% -$28.7K ﹤0.01% 4504
2014
Q3
$579K Buy
72,588
+29,480
+68% +$270K ﹤0.01% 4471
2014
Q2
$434K Buy
43,108
+9,094
+27% +$86.3K ﹤0.01% 4687
2014
Q1
$313K Buy
34,014
+28,479
+515% +$286K ﹤0.01% 4864
2013
Q4
$64K Buy
5,535
+2,943
+114% +$41.5K ﹤0.01% 5510
2013
Q3
$44K Sell
2,592
-15,869
-86% -$274K ﹤0.01% 5210
2013
Q2
$300K Buy
+18,461
New +$296K ﹤0.01% 4603

Other funds holding LFVN

Morgan Stanley's LFVN Position: Q1 2026 in Review

Morgan Stanley increased its LifeVantage (LFVN) stake by 15% in Q1 2026, buying an estimated $62.1K and bringing the position to 91,743 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #5590.

Morgan Stanley first reported a position in LFVN in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.21M in Q1 2021. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • Morgan Stanley held 91,743 shares of LifeVantage worth $396K as of Q1 2026.
  • Morgan Stanley bought 11,853 LifeVantage shares in Q1 2026, an estimated $62.1K.
  • LifeVantage made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5590 holding.
  • Morgan Stanley first reported a position in LifeVantage in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's LifeVantage position peaked at $3.21M in Q1 2021.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.